Optimisation of antiepileptic drug therapy. The importance of serum drug concentration monitoring
- PMID: 8853934
- DOI: 10.2165/00003088-199631020-00004
Optimisation of antiepileptic drug therapy. The importance of serum drug concentration monitoring
Abstract
The ability to measure the serum concentrations of antiepileptic drugs, and the widespread use of this procedure, has markedly improved the treatment given to patients with epilepsy during the past 3 decades. The monitoring of antiepileptic drug concentrations in serum is necessary for the optimal drug therapy of seizures, because the therapeutic and toxic effects of these drugs are better related to serum concentration than to administered dosage. Monitoring appeared to have a major impact on improving the effectiveness and safety of antiepileptic drug therapy. The age-related variability of pharmacokinetic parameters may also require the individualisation of therapy, with subsequent re-evaluation as the person grows older. Monitoring serum concentrations of antiepileptic drugs may help to optimise the dose. A drug concentration, however, can only be regarded as a guide around which to alter the dosage according to the patient's clinical condition. Serum drug concentration monitoring is particularly useful to ensure compliance and in helping to manage combinations of antiepileptic drugs that invariably interact. The addition or deletion of other antiepileptic drugs may change dosage requirements. Therefore, routine monitoring of antiepileptic drug serum concentrations would be extremely useful, especially in the paediatric population, and in patients who require associated antiepileptic medication.
Similar articles
-
Evaluation of therapeutic drug level monitoring of phenobarbital, phenytoin and carbamazepine in Iranian epileptic patients.Int J Clin Pharmacol Ther. 2007 Feb;45(2):121-5. doi: 10.5414/cpp45121. Int J Clin Pharmacol Ther. 2007. PMID: 17323792
-
Therapeutic drug monitoring of antiepileptic drugs.JNMA J Nepal Med Assoc. 2008 Jul-Sep;47(171):94-7. JNMA J Nepal Med Assoc. 2008. PMID: 19079370
-
Evaluation of therapeutic drug monitoring of antiepileptic drugs.Int J Clin Pharmacol Ther. 2003 Mar;41(3):126-31. Int J Clin Pharmacol Ther. 2003. PMID: 12665161
-
Antiepileptic therapeutic drug monitoring.Clin Lab Med. 1981 Sep;1(3):479-500. Clin Lab Med. 1981. PMID: 6809398 Review.
-
Standards of laboratory practice: antiepileptic drug monitoring. National Academy of Clinical Biochemistry.Clin Chem. 1998 May;44(5):1085-95. Clin Chem. 1998. PMID: 9590393 Review.
Cited by
-
A limited sampling method for the estimation of AUC and Cmax of carbamazepine and carbamazepine epoxide following a single and multiple dose of a sustained-release product.Br J Clin Pharmacol. 1998 Mar;45(3):241-6. doi: 10.1046/j.1365-2125.1998.00668.x. Br J Clin Pharmacol. 1998. PMID: 9517367 Free PMC article. Clinical Trial.
-
Inherent correlation between dose and clearance in therapeutic drug monitoring settings: possible misinterpretation in population pharmacokinetic analyses.J Pharmacokinet Pharmacodyn. 2005 Dec;32(5-6):703-18. doi: 10.1007/s10928-005-0083-6. J Pharmacokinet Pharmacodyn. 2005. PMID: 16328100
-
Drug repositioning targeting glutaminase reveals drug candidates for the treatment of Alzheimer's disease patients.J Transl Med. 2023 May 20;21(1):332. doi: 10.1186/s12967-023-04192-6. J Transl Med. 2023. PMID: 37210557 Free PMC article.
-
Pharmacokinetic modelling of valproic acid from routine clinical data in Egyptian epileptic patients.Eur J Clin Pharmacol. 2004 Jan;59(11):783-90. doi: 10.1007/s00228-003-0699-7. Epub 2003 Dec 12. Eur J Clin Pharmacol. 2004. PMID: 14673555
-
Effect of lamotrigine on the pharmacokinetics of carbamazepine and its active metabolite in dogs.Eur J Drug Metab Pharmacokinet. 2001 Jul-Sep;26(3):149-53. doi: 10.1007/BF03190390. Eur J Drug Metab Pharmacokinet. 2001. PMID: 11695714
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous